Cryoport Inc (CYRX) 0.7151 $CYRX
Cryoport Expands Logistics Support to Capricor's DYNAMIC Clinical Trial for Heart Failure
PR Newswire - Tue Apr 07, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that the Company has expanded its relationship with Capricor Therapeutics ("Capricor" to provide a comprehensive cryogenic logistics solution to support both their ALLSTAR and DYNAMIC clinical trials.
CAPR: 8.00 (unch)
Cryoport has Been Engaged by Roslin Cells for Logistics Support of Roslin's iPSC service
PR Newswire - Tue Mar 31, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that it has been engaged to provide its cryogenic logistics services to Roslin Cells of Edinburgh, United Kingdom in support of Roslin's induced pluripotent stem cell (iPSC) reprogramming service.
CombiMatrix Selects Cryoport as Logistics Partner for the Distribution of Its New Genetic Screening Service
PR Newswire - Tue Mar 24, 7:30AM CDT
CombiMatrix Corporation (NASDAQ: CBMX) and Cryoport, Inc. (OTCBB: CYRX), today announced CombiMatrix has selected Cryoport as its cryogenic logistics partner for the distribution of its new CombiPGS(TM) genetic screening test.
CBMX: 1.93 (+0.04)
Cryoport Introduces New Tamper-Proof Lock on its Cryoport Express(R) Shippers for Animal Husbandry
PR Newswire - Wed Mar 18, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company introduced Vet SecureSM, a new tamper-proof lock on its Cryoport Express® Shippers for exclusive use in the global animal husbandry market.
Cryoport Co-Sponsors the Alliance for Regenerative Medicine 3rd Annual REGENMED Investor Day
PR Newswire - Wed Mar 11, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that it is co-sponsoring the Alliance for Regenerative Medicine 3rd Annual REGENMED Investor Day, to be held March 25, 2015 at the Metropolitan Club in New York City.
Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division
PR Newswire - Tue Mar 03, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the expansion of its relationship with Fred Hutchinson Cancer Research Centers' ("Fred Hutch" Clinical Research Division with the inclusion of additional labs to be supported by Cryoport's validated cryogenic logistics solutions for its cell-based therapies.
Cryoport Launches New Logistics Service Supporting Facility Relocation of Cryogenically Frozen Sample Collections
PR Newswire - Tue Feb 17, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the launch of a new logistics service supporting complete facility relocation of critical cryogenically frozen sample collections.
Cryoport Initiates Support of the Growing In-Vitro Fertilization Market in Nepal
PR Newswire - Tue Feb 10, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it has initiated support of the growing in-vitro fertilization ("IVF" market in Nepal.
CryoPort's (CYRX) CEO Jerrell Shelton on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 05, 2:08PM CST
Cryoport EPS of -$0.03
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 7:36AM CST
Cryoport Reports Record Results; Grows Revenue by 50% for the First Nine Months of Fiscal 2015
PR Newswire - Thu Feb 05, 7:30AM CST
Cryoport, Inc. (CYRX) today announced financial results for its fiscal third quarter and nine months ended December 31, 2014.
Cryoport to Report Financial Results for Fiscal Third Quarter of 2015 and Provide Business Update on Thursday, February 5th
PR Newswire - Thu Jan 29, 11:17AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it will release its financial results for the fiscal third quarter ended December 31, 2014 on Thursday, February 5th.
Cryoport Expands Sales Force To Address Growing Life Sciences Industry Demand
PR Newswire - Mon Jan 26, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced the expansion and restructuring of its national sales force in the United States.
Cryoport Appoints Mark W. Sawicki as Chief Commercial Officer to Lead Sales and Marketing Team
PR Newswire - Tue Jan 20, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ( "Company", the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced the appointment of Mark W. Sawicki, Ph.D. as Chief Commercial Officer of Cryoport Systems.
Cryoport Appoints Richard J. Berman to its Board of Directors
PR Newswire - Mon Jan 12, 7:36AM CST
Cryoport, Inc. (OTC BB:CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, contract research organizations, vaccine manufacturers, and IVF, today announced the appointment of Richard J. Berman to its Board of Directors. Mr. Berman will also serve as Chairman of the Audit Committee and Compensation Committee.
Cryoport Designated as Exclusive Cryogenic Logistics Provider to Triangle Research Labs
PR Newswire - Mon Dec 29, 7:30AM CST
Cryoport, Inc. (OTC BB: CYRX) ("the Company", the leading provider of advanced cryogenic logistics solutions for life sciences, announced today that it has entered into an agreement with Triangle Research Labs, LLC ("TRL". Under the agreement, Cryoport becomes the exclusive cryogenic logistics provider for TRL, providing it with the ability to support its overall demand growth and meet its ever-increasing demand for same day cryogenic shipping.
Cryoport Increases Revenue by 65% for the First Six Months of Fiscal 2015
PR Newswire - Wed Nov 12, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for its second quarter and six months ended September 30, 2014.
Cryoport & UPS Collaborate on Cryogenic Logistics Solutions for the Healthcare Industry
PR Newswire - Mon Nov 03, 1:27PM CST
Cryoport, Inc. (OTC BB: CYRX) ("the Company", the leading provider of advanced cryogenic logistics solutions, announced today that it is collaborating with UPS to enhance its temperature-sensitive shipping offerings to the healthcare industry.
Cryoport Begins Delivering Novel Cryogenically Preserved Knee OA Treatment to Orthopedists
PR Newswire - Tue Oct 14, 7:00AM CDT
Cryoport, Inc. (OTC:CYRX) announced today the first phase of deploying its "Regenerative Medicine Point-of-Care Repository Solution" for Liventa Bioscience's introduction of Liventa's AmnioClear® LCT therapy to orthopedic clinics in the US. More than 70 orthopedic clinics have expressed interest in the therapy. Of these clinics, approximately 20 have entered into a registry/ clinical study with Liventa.
Cryoport Engages Broekman Group to Enhance Its Logistics and Operational Support in Europe
PR Newswire Europe - Tue Sep 16, 7:03AM CDT
- New "state-of-the-art" operations center to provide convenient, comprehensive cryogenic logistics support for Cryoport's European client base
Cryoport Expands Logistics Support to Capricor's DYNAMIC Clinical Trial for Heart Failure
PR Newswire - Tue Apr 07, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that the Company has expanded its relationship with Capricor Therapeutics ("Capricor" to provide a comprehensive cryogenic logistics solution to support both their ALLSTAR and DYNAMIC clinical trials. CAPR: 8.00 (unch)
Cryoport has Been Engaged by Roslin Cells for Logistics Support of Roslin's iPSC service
PR Newswire - Tue Mar 31, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that it has been engaged to provide its cryogenic logistics services to Roslin Cells of Edinburgh, United Kingdom in support of Roslin's induced pluripotent stem cell (iPSC) reprogramming service. CombiMatrix Selects Cryoport as Logistics Partner for the Distribution of Its New Genetic Screening Service
PR Newswire - Tue Mar 24, 7:30AM CDT
CombiMatrix Corporation (NASDAQ: CBMX) and Cryoport, Inc. (OTCBB: CYRX), today announced CombiMatrix has selected Cryoport as its cryogenic logistics partner for the distribution of its new CombiPGS(TM) genetic screening test.
CBMX: 1.93 (+0.04)
Cryoport Introduces New Tamper-Proof Lock on its Cryoport Express(R) Shippers for Animal Husbandry
PR Newswire - Wed Mar 18, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for the life sciences industry serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company introduced Vet SecureSM, a new tamper-proof lock on its Cryoport Express® Shippers for exclusive use in the global animal husbandry market. Cryoport Co-Sponsors the Alliance for Regenerative Medicine 3rd Annual REGENMED Investor Day
PR Newswire - Wed Mar 11, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that it is co-sponsoring the Alliance for Regenerative Medicine 3rd Annual REGENMED Investor Day, to be held March 25, 2015 at the Metropolitan Club in New York City. Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division
PR Newswire - Tue Mar 03, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the expansion of its relationship with Fred Hutchinson Cancer Research Centers' ("Fred Hutch" Clinical Research Division with the inclusion of additional labs to be supported by Cryoport's validated cryogenic logistics solutions for its cell-based therapies. Cryoport Launches New Logistics Service Supporting Facility Relocation of Cryogenically Frozen Sample Collections
PR Newswire - Tue Feb 17, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the launch of a new logistics service supporting complete facility relocation of critical cryogenically frozen sample collections. Cryoport Initiates Support of the Growing In-Vitro Fertilization Market in Nepal
PR Newswire - Tue Feb 10, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it has initiated support of the growing in-vitro fertilization ("IVF" market in Nepal. CryoPort's (CYRX) CEO Jerrell Shelton on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 05, 2:08PM CST
Cryoport EPS of -$0.03
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 7:36AM CST
Cryoport Reports Record Results; Grows Revenue by 50% for the First Nine Months of Fiscal 2015
PR Newswire - Thu Feb 05, 7:30AM CST
Cryoport, Inc. (CYRX) today announced financial results for its fiscal third quarter and nine months ended December 31, 2014.
Cryoport to Report Financial Results for Fiscal Third Quarter of 2015 and Provide Business Update on Thursday, February 5th
PR Newswire - Thu Jan 29, 11:17AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it will release its financial results for the fiscal third quarter ended December 31, 2014 on Thursday, February 5th. Cryoport Expands Sales Force To Address Growing Life Sciences Industry Demand
PR Newswire - Mon Jan 26, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced the expansion and restructuring of its national sales force in the United States. Cryoport Appoints Mark W. Sawicki as Chief Commercial Officer to Lead Sales and Marketing Team
PR Newswire - Tue Jan 20, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ( "Company"
, the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced the appointment of Mark W. Sawicki, Ph.D. as Chief Commercial Officer of Cryoport Systems. Cryoport Appoints Richard J. Berman to its Board of Directors
PR Newswire - Mon Jan 12, 7:36AM CST
Cryoport, Inc. (OTC BB:CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, contract research organizations, vaccine manufacturers, and IVF, today announced the appointment of Richard J. Berman to its Board of Directors. Mr. Berman will also serve as Chairman of the Audit Committee and Compensation Committee. Cryoport Designated as Exclusive Cryogenic Logistics Provider to Triangle Research Labs
PR Newswire - Mon Dec 29, 7:30AM CST
Cryoport, Inc. (OTC BB: CYRX) ("the Company"
, the leading provider of advanced cryogenic logistics solutions for life sciences, announced today that it has entered into an agreement with Triangle Research Labs, LLC ("TRL". Under the agreement, Cryoport becomes the exclusive cryogenic logistics provider for TRL, providing it with the ability to support its overall demand growth and meet its ever-increasing demand for same day cryogenic shipping. Cryoport Increases Revenue by 65% for the First Six Months of Fiscal 2015
PR Newswire - Wed Nov 12, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for its second quarter and six months ended September 30, 2014.
Cryoport & UPS Collaborate on Cryogenic Logistics Solutions for the Healthcare Industry
PR Newswire - Mon Nov 03, 1:27PM CST
Cryoport, Inc. (OTC BB: CYRX) ("the Company"
, the leading provider of advanced cryogenic logistics solutions, announced today that it is collaborating with UPS to enhance its temperature-sensitive shipping offerings to the healthcare industry. Cryoport Begins Delivering Novel Cryogenically Preserved Knee OA Treatment to Orthopedists
PR Newswire - Tue Oct 14, 7:00AM CDT
Cryoport, Inc. (OTC:CYRX) announced today the first phase of deploying its "Regenerative Medicine Point-of-Care Repository Solution" for Liventa Bioscience's introduction of Liventa's AmnioClear® LCT therapy to orthopedic clinics in the US. More than 70 orthopedic clinics have expressed interest in the therapy. Of these clinics, approximately 20 have entered into a registry/ clinical study with Liventa.
Cryoport Engages Broekman Group to Enhance Its Logistics and Operational Support in Europe
PR Newswire Europe - Tue Sep 16, 7:03AM CDT
- New "state-of-the-art" operations center to provide convenient, comprehensive cryogenic logistics support for Cryoport's European client base
